FDCDDQ
MRNA icon

Federation des caisses Desjardins du Quebec’s Moderna MRNA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.91M Buy
41,572
+3,685
+10% +$191K 0.01% 677
2026
Q1 		$1.92M Sell
37,887
-7,049
-16% -$329K 0.01% 763
2025
Q4 		$1.33M Buy
44,936
+1,346
+3% +$36.6K 0.01% 871
2025
Q3 		$1.13M Buy
43,590
+19,100
+78% +$533K ﹤0.01% 908
2025
Q2 		$676K Sell
24,490
-7,021
-22% -$185K ﹤0.01% 968
2025
Q1 		$893K Buy
31,511
+166
+0.5% +$5.89K ﹤0.01% 858
2024
Q4 		$1.3M Buy
31,345
+276
+0.9% +$13.2K 0.01% 734
2024
Q3 		$2.08M Buy
31,069
+682
+2% +$62.6K 0.01% 572
2024
Q2 		$3.61M Sell
30,387
-2,013
-6% -$255K 0.02% 401
2024
Q1 		$3.32M Buy
32,400
+808
+3% +$81.4K 0.02% 398
2023
Q4 		$3.14M Sell
31,592
-358
-1% -$30.1K 0.03% 342
2023
Q3 		$3.3M Sell
31,950
-4,493
-12% -$501K 0.03% 331
2023
Q2 		$4.43M Sell
36,443
-10,492
-22% -$1.4M 0.04% 303
2023
Q1 		$7.21M Buy
46,935
+1,344
+3% +$222K 0.08% 198
2022
Q4 		$8.19M Sell
45,591
-5,627
-11% -$920K 0.1% 171
2022
Q3 		$6.06M Buy
51,218
+595
+1% +$90.3K 0.07% 206
2022
Q2 		$7.23M Buy
50,623
+3,598
+8% +$514K 0.08% 191
2022
Q1 		$8.1M Buy
47,025
+2,034
+5% +$342K 0.08% 199
2021
Q4 		$11.4M Sell
44,991
-1,044
-2% -$305K 0.11% 158
2021
Q3 		$17.7M Buy
46,035
+3,257
+8% +$1.2M 0.18% 107
2021
Q2 		$10M Sell
42,778
-8,498
-17% -$1.52M 0.1% 168
2021
Q1 		$6.72M Sell
51,276
-4,355
-8% -$631K 0.07% 213
2020
Q4 		$5.81M Buy
55,631
+53,220
+2,207% +$5.38M 0.07% 235
2020
Q3 		$171K Buy
2,411
+1,186
+97% +$82.7K ﹤0.01% 913
2020
Q2 		$78.7K Buy
1,225
+1,075
+717% +$58.9K ﹤0.01% 1099
2020
Q1 		$4.49K Buy
+150
New +$3.45K ﹤0.01% 1846

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's MRNA Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Moderna (MRNA) stake by 9.7% in Q2 2026, buying an estimated $191K and bringing the position to 41,572 shares worth $2.91M. The position accounts for 0.01% of the portfolio, ranked #677.

Federation des caisses Desjardins du Quebec first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $17.7M in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 41,572 shares of Moderna worth $2.91M as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 3,685 Moderna shares in Q2 2026, an estimated $191K.
  • Moderna made up 0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #677 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • Federation des caisses Desjardins du Quebec's Moderna position peaked at $17.7M in Q3 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.